Neuralgic amyotrophy: An update on diagnosis, pathophysiology, and treatment

Muscle and Nerve

Volumn 53, Issue 3, 2016, Pages 337-350

  Van Eijk, Jeroen J J ^a,b   Groothuis, Jan T ^b   Van Alfen, Nens ^b  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Brachial plexus; Clinical feature; Diagnosis; Neuralgic amyotrophy; Treatment

Indexed keywords

CORTICOSTEROID; IMMUNOMODULATING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ANALGESIA; AUTOIMMUNITY; BIOMECHANICS; BRACHIAL PLEXUS NEUROPATHY; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ELECTRODIAGNOSIS; EMERGENCY CARE; ENDURANCE; EXERCISE; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOTHERAPY; INCIDENCE; LABORATORY TEST; MOLECULAR PATHOLOGY; NEUROREHABILITATION; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; BRACHIAL PLEXUS NEURITIS; DISEASE MANAGEMENT; PATHOPHYSIOLOGY;

BRACHIAL PLEXUS NEURITIS; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS;

EID: 84956777716     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.25008     Document Type: Review

References (82)

1. Joffroy A. De la névrite parenchymateuse spontanée, généralisée ou partielle. Arch Physiol 1879;6:172-198.
2. Dreschfeld J. On some of the rarer forms of muscular atrophy. Brain 1886;79:226-232.
3. Parsonage MJ, Turner JW. Neuralgic amyotrophy; the shoulder-girdle syndrome. Lancet 1948;1:973-978.
4. van Alfen N, van Engelen BG. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 2006;129:438-450.
5. van Alfen N, van Eijk JJ, Ennik T, Flynn SO, Nobacht IE, Groothuis JT, et al. Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care setting-a prospective cohort study. PLoS One 2015;10:e0128361.
6. van Alfen N. Clinical and pathophysiological concepts of neuralgic amyotrophy. Nat Rev Neurol 2011;7:315-322.
7. Byrne E. Extended neuralgic amyotrophy syndrome. Aust NZ J Med 1987;17:34-38.
8. England JD, Sumner AJ. Neuralgic amyotrophy: an increasingly diverse entity. Muscle Nerve 1987;10:60-68.
9. Dyck PJ, Thaisetthawatkul P. Lumbosacral plexopathy. Continuum (Minneap Minn) 2014;20:1343-1358.
10. Dyck PJ, Engelstad J, Norell J, Dyck PJ. Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN). J Neuropathol Exp Neurol 2000;59:525-538.
11. Johnson RL, Warner ME, Staff NP, Warner MA. Neuropathies after surgery: anatomical considerations of pathologic mechanisms. Clin Anat 2015;28:678-682.
12. Beghi E, Kurland LT, Mulder DW, Nicolosi A. Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981. Ann Neurol 1985;18:320-323.
13. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123:665-676.
14. Spillane JD. Localized neuritis of the shoulder girdle. A report of 46 patients in the MEF. Lancet 1943;242:532-535.
15. van Alfen N, Huisman WJ, Overeem S, van Engelen BG, Zwarts MJ. Sensory nerve conduction studies in neuralgic amyotrophy. Am J Phys Med Rehabil 2009;88:941-946.
16. van Alfen N, Schuuring J, van Engelen BG, Rotteveel JJ, Gabreëls FJ. Idiopathic neuralgic amyotrophy in children. A distinct phenotype compared to the adult form. Neuropediatrics 2000;31:328-332.
17. Dunn HG, Daube JR, Gomez MR. Heredofamilial branchial plexus neuropathy (hereditary neuralgic amyotrophy with branchial predilection) in childhood. Dev Med Child Neurol 1978;20:28-46.
18. Høst C, Skov L. Idiopathic neuralgic amyotrophy in children. Case report, 4 year follow up and review of the literature. Eur J Paediatr Neurol 2010;14:467-473.
19. Yamada K, Mano T, Toribe Y, Yanagihara K, Suzuki Y. MRI findings and steroid therapy for neuralgic amyotrophy in children. Pediatr Neurol 2011;45:200-202.
20. Zeharia A, Mukamel M, Frishberg Y, Weitz R, Mimouni M. Benign plexus neuropathy in children. J Pediatr 1990;116:276-278.
21. van Alfen N, Hannibal MC, Chance PF, van Engelen BGM. Hereditary neuralgic amyotrophy. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle 1993-2015. February 27, 2008 [updated 2012 Dec 6].
22. Chance PF, Lensch MW, Lipe H, Brown RH Sr, Brown RH Jr, Bird TD. Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct genetic disorders. Neurology 1994;44:2253-2257.
23. Gouider R, LeGuern E, Emile J, Tardieu S, Cabon F, Samid M, et al. Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct clinical, electrophysiologic, and genetic entities. Neurology 1994;44:2250-2252.
24. Pellegrino JE, Rebbeck TR, Brown MJ, Bird TD, Chance PF. Mapping of hereditary neuralgic amyotrophy (familial brachial plexus neuropathy) to distal chromosome 17q. Neurology 1996;46:1128-1132.
25. Stögbauer F, Young P, Timmerman V, Spoelders P, Ringelstein EB, van Broeckhoven C, et al. Refinement of the hereditary neuralgic amyotrophy (HNA) locus to chromosome 17q24-q25. Hum Genet 1997;99:685-687.
26. Kuhlenbäumer G, Hannibal MC, Nelis E, Schirmacher A, Verpoorten N, Meuleman J, et al. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet 2005;37:1044-1046.
27. Hannibal MC, Ruzzo EK, Miller LR, Betz B, Buchan JG, Knutzen DM, et al. SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy. Neurology 2009;72:1755-1759.
28. Klein CJ, Wu Y, Cunningham JM, Windebank AJ, Dyck PJ, Friedenberg SM, et al. SEPT9 mutations and a conserved 17q25 sequence in sporadic and hereditary brachial plexus neuropathy. Arch Neurol 2009;66:238-243.
29. Landsverk ML, Ruzzo EK, Mefford HC, Buysse K, Buchan JG, Eichler EE, et al. Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy. Hum Mol Genet 2009;18:1200-1208.
30. Watts GD, O'Briant KC, Chance PF. Evidence of a founder effect and refinement of the hereditary neuralgic amyotrophy (HNA) locus on 17q25 in American families. Hum Genet 2002;110:166-172.
31. Collie AM, Landsverk ML, Ruzzo E, Mefford HC, Buysse K, Adkins JR, et al. Non-recurrent SEPT9 duplications cause hereditary neuralgic amyotrophy. J Med Genet 2010;47:601-607.
32. Dartevel A, Colombe B, Bosseray A, Larrat S, Sarrot-Reynauld F, Belbezier A, et al. Hepatitis E and neuralgic amyotrophy: five cases and review of literature. J Clin Virol 2015;69:156-164.
33. van Eijk JJ, Madden RG, van der Eijk AA, Hunter JG, Reimerink JH, Bendall RP, et al. Neuralgic amyotrophy and hepatitis E virus infection. Neurology 2014;82:498-503.
34. Stek CJ, van Eijk JJ, Jacobs BC, Enting RH, Sprenger HG, van Alfen N, et al. Neuralgic amyotrophy associated with Bartonella henselae infection. J Neurol Neurosurg Psychiatry 2011;82:707-708.
35. Klein CJ, Dyck PJ, Friedenberg SM, Burns TM, Windebank AJ, Dyck PJ. Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy. J Neurol Neurosurg Psychiatry 2002;73:45-50.
36. Suarez GA, Giannini C, Bosch EP, Barohn RJ, Wodak J, Ebeling P, et al. Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology 1996;46:559-561.
37. Arts WF, Busch HF, Van den Brand HJ, Jennekens FG, Frants RR, Stefanko SZ. Hereditary neuralgic amyotrophy. Clinical, genetic, electrophysiological and histopathological studies. J Neurol Sci 1983;62:261-279.
38. van Alfen N, Gabreëls-Festen AA, Ter Laak HJ, Arts WF, Gabreëls FJ, van Engelen BG. Histology of hereditary neuralgic amyotrophy. J Neurol Neurosurg Psychiatry 2005;76:445-447.
39. Edwards JCW, Cambridge G, Abrahams VM. Do self-perpetuating B lymphocytes drive human autoimmune disease? Immunology 1999;97:188-196.
40. Pan Y, Wang S, Zheng D, Tian W, Tian G, Ho PC, et al. Hourglass-like constrictions of peripheral nerve in the upper extremity: a clinical review and pathological study. Neurosurgery 2014;75:10-22.
41. Vriesendorp FJ, Dmytrenko GS, Dietrich T, Koski CL. Anti-peripheral nerve myelin antibodies and terminal activation products of complement in serum of patients with acute brachial plexus neuropathy. Arch Neurol 1993;50:1301-1303.
42. Sierra A, Prat J, Bas J, Romeu A, Montero J, Matos JA, et al. Blood lymphocytes are sensitized to branchial plexus nerves in patients with neuralgic amyotrophy. Acta Neurol Scand 1991;83:183-186.
43. Arányi Z, Csillik A, Dévay K, Rosero M, Barsi P, Böhm J, et al. Ultrasonographic identification of nerve pathology in neuralgic amyotrophy: enlargement, constriction, fascicular entwinement, and torsion. Muscle Nerve 2015;52:503-511.
44. Bardos V, Somodska V. Epidemiologic study of a brachial plexus neuritis outbreak in northeast Czechoslovakia. World Neurol 1961;2:973-979.
45. van Alfen N. The trouble with neuralgic amyotrophy. Pract Neurol 2006;6:298-307.
46. van Alfen N, Malessy MJ. Diagnosis of brachial and lumbosacral plexus lesions. Handb Clin Neurol 2013;115:293-310.
47. Louis E, Touzé E, Piketty ML, Salmon-Céron D, Zuber M. Bilateral amyotrophic neuralgia (Parsonage Turner syndrome) with HIV seroconversion [in French]. Rev Neurol (Paris) 2003;159:685-687.
48. Wendling D, Sevrin P, Bouchaud-Chabot A, Chabroux A, Toussirot E, Bardin T, et al. Parsonage-Turner syndrome revealing Lyme borreliosis. Joint Bone Spine 2009;76:202-204.
49. Cup EH, Ijspeert J, Janssen RJ, Bussemaker-Beumer C, Jacobs J, Pieterse AJ, et al. Residual complaints after neuralgic amyotrophy. Arch Phys Med Rehabil 2013;94:67-73.
50. van Eijk JJ, van Alfen N, Tio-Gillen AP, Maas M, Herbrink P, Portier RP, et al. Screening for antecedent Campylobacter jejuni infections and anti-ganglioside antibodies in idiopathic neuralgic amyotrophy. J Peripher Nerv Syst 2011;16:153-156.
51. van Paassen BW, van der Kooi AJ, van Spaendonck-Zwarts KY, Verhamme C, Baas F, de Visser M. PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies. Orphanet J Rare Dis 2014;9:38.
52. Panagopoulos N, Leivaditis V, Koletsis E, Prokakis C, Alexopoulos P, Baltayiannis N, et al. Pancoast tumors: characteristics and preoperative assessment. J Thorac Dis 2014;6(suppl 1):S108-115.
53. Tsao BE, Ostrovskiy DA, Wilbourn AJ, Shields RW Jr. Phrenic neuropathy due to neuralgic amyotrophy. Neurology 2006;66:1582-1584.
54. Boon AJ, Sekiguchi H, Harper CJ, Strommen JA, Ghahfarokhi LS, Watson JC, et al. Sensitivity and specificity of diagnostic ultrasound in the diagnosis of phrenic neuropathy. Neurology 2014;83:1264-1270.
55. Duman I, Guvenc I, Kalyon TA. Neuralgic amyotrophy, diagnosed with magnetic resonance neurography in acute stage: a case report and review of the literature. Neurologist 2007;13:219-221.
56. Johnson NE, Petraglia AL, Huang JH, Logigian EL. Rapid resolution of severe neuralgic amyotrophy after treatment with corticosteroids and intravenous immunoglobulin. Muscle Nerve 2011;44:304-305.
57. Zara G, Gasparotti R, Manara R. MR imaging of peripheral nervous system involvement: Parsonage-Turner syndrome. J Neurol Sci 2012;315:170-171.
58. Zhou L, Yousem DM, Chaudhry V. Role of magnetic resonance neurography in brachial plexus lesions. Muscle Nerve 2004;30:305-309.
59. Corato M, De Nittis P, Trenti N, Paganoni S. Teaching neuroImages: median nerve MRI changes over time in neuralgic amyotrophy. Neurology 2014;82:e79.
60. Nakashima H, Yukawa Y, Suda K, Yamagata M, Ueta T, Kato F. Abnormal findings on magnetic resonance images of the cervical spines in 1211 asymptomatic subjects. Spine (Phila Pa 1976) 2015;40:392-398.
61. Suk JI, Walker FO, Cartwright MS. Ultrasonography of peripheral nerves. Curr Neurol Neurosci Rep 2013;13:328.
62. Goedee HS, Brekelmans GJ, van Asseldonk JT, Beekman R, Mess WH, Visser LH. High resolution sonography in the evaluation of the peripheral nervous system in polyneuropathy-a review of the literature. Eur J Neurol 2013;20:1342-1351.
63. van Alfen N, van Engelen BG, Hughes RA. Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). Cochrane Database Syst Rev 2009b;(3):CD006976. Updated 2012.
64. van Eijk JJ, van Alfen N, Berrevoets M, van der Wilt GJ, Pillen S, van Engelen BG. Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy: an observational study. J Neurol Neurosurg Psychiatry 2009;80:1120-1124.
65. Moriguchi K, Miyamoto K, Takada K, Kusunoki S. Four cases of anti-ganglioside antibody-positive neuralgic amyotrophy with good response to intravenous immunoglobulin infusion therapy. J Neuroimmunol 2011;238:107-109.
66. Nakajima M, Fujioka S, Ohno H, Iwamoto K. Partial but rapid recovery from paralysis after immunomodulation during early stage of neuralgic amyotrophy. Eur Neurol 2006;55:227-229.
67. Naito KS, Fukushima K, Suzuki S, Kuwahara M, Morita H, Kusunoki S, et al. Intravenous immunoglobulin (IVIg) with methylprednisolone pulse therapy for motor impairment of neuralgic amyotrophy: clinical observations in 10 cases. Intern Med 2012;51:1493-1500.
68. Klein CJ, Barbara DW, Sprung J, Dyck PJ, Weingarten TN. Surgical and postpartum hereditary brachial plexus attacks and prophylactic immunotherapy. Muscle Nerve 2013;47:23-27.
69. van Eijk JJ, van Alfen N. Surgical and postpartum hereditary brachial plexus attacks and prophylactic immunotherapy. Muscle Nerve 2013;48:624.
70. Pan YW, Wang S, Tian G, Li C, Tian W, Tain M. Typical brachial neuritis (Parsonage-Turner syndrome) with hourglass constriction in the affected nerves. J Hand Surg Am 2011;36:1197-1203.
71. Bertelli JA, Ghizoni MF. Nerve transfer from triceps medial head and anconeus to deltoid for axillary nerve palsy. J Hand Surg Am 2014;39:940-947.
72. van Alfen N, van Engelen BG, Reinders JW, Kremer H, Gabreels FJ. The natural history of hereditary neuralgic amyotrophy in the Dutch population: two distinct types? Brain 2000;123:718-723.
73. van Alfen N, van der Werf SP, van Engelen BG. Long-term pain, fatigue, and impairment in neuralgic amyotrophy. Arch Phys Med Rehabil 2009;90:435-439.
74. Geertzen JH, Groothoff JW, Nicolai JP, Rietman JS. Brachial plexus neuropathy. A long-term outcome study. J Hand Surg [Br] 2000;25:461-464.
75. Tsairis P, Dyck PJ, Mulder DW. Natural history of brachial plexus neuropathy. Report on 99 patients. Arch Neurol 1972;27:109-117.
76. Tonali P, Uncini A, Di Pasqua PG. So-called neuralgic amyotrophy: clinical features and long term follow-up. Ital J Neurol Sci 1983;4:431-437.
77. Cruz-Martinez A, Barrio M, Arpa J. Neuralgic amyotrophy: variable expression in 40 patients. J Peripher Nerv Syst 2002;7:198-204.
78. Turner JW, Parsonage MJ. Neuralgic amyotrophy (paralytic brachial neuritis); with special reference to prognosis. Lancet 1957;270:209-212.
79. Ijspeert J, Janssen RM, Murgia A, Pisters MF, Cup EH, Groothuis JT, et al. Efficacy of a combined physical and occupational therapy intervention in patients with subacute neuralgic amyotrophy: a pilot study. NeuroRehabilitation 2013;33:657-665.
80. Worsley P, Warner M, Mottram S, Gadola S, Veeger HE, Hermens H, et al. Motor control retraining exercises for shoulder impingement: effects on function, muscle activation, and biomechanics in young adults. J Shoulder Elbow Surg 2013;22:e11-19.
81. Garssen MP, Schillings ML, van Doorn PA, Van Engelen BG, Zwarts MJ. Contribution of central and peripheral factors to residual fatigue in Guillain-Barré syndrome. Muscle Nerve 2007;36:93-99.
82. Rollnick S, Miller WR. What is motivational interviewing? Behav Cogn Psychother 1995;23:325-334.